|
Ulixertinib
|
|
869886-67-9
|
|
AL 8697
|
|
1057394-06-5
|
|
SR-318
|
|
2413286-32-3
|
|
PD318088
|
|
391210-00-7
|
|
VX-11e
|
|
896720-20-0
|
|
Agerafenib
|
|
1188910-76-0
|
|
B-Raf inhibitor 1
|
|
1093100-40-3
|
|
Tanzisertib
|
|
899805-25-5
|
|
HG6-64-1
|
|
1315329-43-1
|
|
5Z-7-Oxozeaenol
|
|
253863-19-3
|
|
TC ASK 10
|
|
1005775-56-3
|
|
MW-150
|
|
1628502-91-9
|
|
AZ 628
|
|
878739-06-1
|
|
PF-4708671
|
|
1255517-76-0
|
|
AT7867
|
|
857531-00-1
|
|
ERK5-IN-1
|
|
1234479-76-5
|
|
NG25
|
|
1315355-93-1
|
|
JNK-IN-7
|
|
1408064-71-0
|
|
p38 MAPK-IN-1
|
|
1006378-90-0
|
|
GW806742X
|
|
579515-63-2
|
|
BMS-582949 hydrochloride
|
|
912806-16-7
|
|
CC-90003
|
|
1621999-82-3
|
|
PROTAC B-Raf degrader 1
|
|
2364367-27-9
|
|
Hypothemycin
|
|
76958-67-3
|
|
Regorafenib
|
|
755037-03-7
|
|
Trametinib
|
|
871700-17-3
|
|
Pluripotin
|
|
839707-37-8
|
|
TAK-580
|
|
1096708-71-2
|
|
Dabrafenib
|
|
1195765-45-7
|
|
DB07268
|
|
929007-72-7
|
|
Cobimetinib hemifumarate
|
|
1369665-02-0
|
|
ETC-206
|
|
1464151-33-4
|
|
MK-8353
|
|
1184173-73-6
|
|
Tpl2 Kinase Inhibitor 1
|
|
871307-18-5
|
|
SL327
|
|
305350-87-2
|
|
SB-590885
|
|
405554-55-4
|
|
TAK-733
|
|
1035555-63-5
|
|
AS601245
|
|
345987-15-7
|
|
Encorafenib
|
|
1269440-17-6
|
|
AZ304
|
|
942507-42-8
|
|
CKI-7 free base
|
|
120615-25-0
|
|
RWJ-67657
|
|
215303-72-3
|
|
Refametinib
|
|
923032-37-5
|
|
Regorafenib Hydrochloride
|
|
835621-07-3
|
|
Regorafenib monohydrate
|
|
1019206-88-2
|
|
LY-2584702 tosylate salt
|
|
1082949-68-5
|
|
AZD7624
|
|
1095004-78-6
|
|
UM-164
|
|
903564-48-7
|
|
5,6,7-Trimethoxyflavone
|
|
973-67-1
|
|
GW284543
|
|
790186-68-4
|
|
Dilmapimod
|
|
444606-18-2
|
|
XMD17-109
|
|
1435488-37-1
|
|
KO-947
|
|
1695533-89-1
|
|
ZM 336372
|
|
208260-29-1
|
|
ERK1/2 inhibitor 2
|
|
2095719-92-7
|
|
BAY885
|
|
2307249-33-6
|
|
Belvarafenib
|
|
1446113-23-0
|
|
p38α inhibitor 1
|
|
1034189-82-6
|
|
LUT014
|
|
2274819-46-2
|
|
CMPD1
|
|
41179-33-3
|
|
FR 180204
|
|
865362-74-9
|
|
RO4987655
|
|
874101-00-5
|
|
U0126-EtOH
|
|
1173097-76-1
|
|
BIX02188
|
|
334949-59-6
|
|
Dabrafenib Mesylate
|
|
1195768-06-9
|
|
Cobimetinib racemate
|
|
934662-91-6
|
|
GDC-0623
|
|
1168091-68-6
|
|
LY3009120
|
|
1454682-72-4
|
|
Guggulsterone
|
|
95975-55-6
|
|
KY-05009
|
|
1228280-29-2
|
|
SLV-2436
|
|
2095704-43-9
|
|
Talmapimod
|
|
309913-83-5
|
|
AZD8330
|
|
869357-68-6
|
|
JNK Inhibitor VIII
|
|
894804-07-0
|
|
GSK-25
|
|
874119-56-9
|
|
BIX02189
|
|
1265916-41-3
|
|
JNK-IN-8
|
|
1410880-22-6
|
|
AT7867 dihydrochloride
|
|
1431697-86-7
|
|
CC-401 hydrochloride
|
|
1438391-30-0
|
|
BI-D1870
|
|
501437-28-1
|
|
BI-882370
|
|
1392429-79-6
|
|
JWG-071
|
|
2250323-50-1
|
|
MK-2 Inhibitor III
|
|
1186648-22-5
|
|
Ulixertinib hydrochloride
|
|
1956366-10-1
|
|
DLK-IN-1
|
|
1620574-24-4
|
|
WHI-P258
|
|
21561-09-1
|
|
SR-3306
|
|
1128096-91-2
|
|
SL 0101-1
|
|
77307-50-7
|
|
ERK1/2 inhibitor 1
|
|
2095719-90-5
|
|
Pimasertib
|
|
1236699-92-5
|
|
Bentamapimod
|
|
848344-36-5
|
|
Trametinib (DMSO solvate)
|
|
1187431-43-1
|
|
CCT196969
|
|
1163719-56-9
|
|
AZD-0364
|
|
2097416-76-5
|
|
IQ-3
|
|
312538-03-7
|
|
TBAP-001
|
|
1777832-90-2
|
|
DMX-5804
|
|
2306178-56-1
|
|
ERK5-IN-2
|
|
1888305-96-1
|
|
(rel)-AR234960
|
|
1408311-94-3
|
|
RRD-251
|
|
72214-67-6
|